Cochlear Americas Receives FDA Approval

barbara.lempert Cochlear Americas Receives FDA Approval for the First and Only Ear Level Accessory for Waterproof Hearing with Cochlear Implants The Aqua Accessory allows recipients ...

Shire Settles Patent Infringement Lawsuit Against Teva Concerning Intuniv

barbara.lempert Shire Settles Patent Infringement Lawsuit Against Teva Concerning INTUNIV® PHILADELPHIA, May 31, 2013 /PRNewswire/ — Shire LLC has settled its litigation against ...

FDA oncology chief Pazdur vows to accelerate “breakthrough” drug R&D

John Carroll FierceBiotech News

Big Ten Universities Form Big Ten Cancer Research Consortium

barbara.lempert Big Ten universities form Big Ten Cancer Research Consortium INDIANAPOLIS, May 31, 2013 /PRNewswire-USNewswire/ — In athletics, the Big Ten universities compete ...

New Mobile App Assists Oncologists In Navigating Ever-Evolving Sea Of Cancer Information

barbara.lempert Lilly Oncology partners with MDLinx to make new research easily accessible INDIANAPOLIS, May 31, 2013 /PRNewswire/ — Recent advancements in cancer research ...

E Keppra Tablet Approved in Japan for Pediatric Epilepsy

barbara.lempert Antiepileptic Drug E Keppra® Tablet Approved in Japan for Pediatric Epilepsy (Partial-Onset Seizures)Epilepsy occurs most frequently in infants and elderly, and it ...

Outspoken doctor’s pancreas study prompted FDA’s new diabetes-drug probe

Carly Helfand Inconclusive data, confounding variables, as-yet-unreplicated results–they're all reasons critics have dismissed a link between incretin mimetics, a class of ...

Micamlo Launched in Japan

barbara.lempert Launch of Japan’s First High-Dose ARB and CCB Combination:”Micamlo® Combination Tablets BP” - powerful antihypertensive effect lasting 24 hours ...

Achillion CEO retires, Chief Scientific Officer Deshpande to step into role

Alok Saboo FierceBiotech News

Bayer wins NICE backing for fast-growing Lucentis challenger, Eylea

Tracy Staton Bayer and Regeneron's hard-charging eye drug has traded its way to another victory. It won a recommendation from the U.K.'s cost-effectiveness watchdogs, on the ...

ChemoCentryx Announces Appointment of Health Care Insurance Executive Ira Klein, MD, to Company’s Board of Directors

barbara.lempert ChemoCentryx Announces Appointment of Health Care Insurance  Executive Ira Klein, MD, to Company’s Board of Directors MOUNTAIN VIEW, Calif., May 28, 2013 (GLOBE ...

EMA backs approval of key drugs from Celgene and Aegerion

Ryan McBride Two drugmakers reported regulatory victories for therapies in the important European market. A European Medicines Agency committee endorsed approval of Celgene's ($ ...
Page 1 of 3412345...102030...Last »
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS